查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1766351

药物筛选市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Drug Screening Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年，全球药物筛检市场规模达138亿美元，预计年复合成长率将达14.5%，到2034年将达到522亿美元。这一增长得益于人们对药物滥用问题的日益关注、药物检测技术的进步，以及就业、体育和医疗保健等各个领域出台的更严格政策。世界各国政府正在加强打击药物滥用的力度，这进一步刺激了市场对有效筛检解决方案的需求。

药物筛选市场 - IMG1

液相层析质谱法 (LC-MS) 和免疫分析等尖端技术显着提高了药物筛检流程的准确性和效率。此外，快速筛检试剂盒和现场检测设备的普及也使筛检流程更加便捷，并缩短了获得结果所需的时间。这使得药物筛检解决方案对于工作场所安全和合规性至关重要，尤其是在《无毒品工作场所法案》等法规的监管下，该法案已成为市场扩张的驱动力。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 138亿美元
预测值 522亿美元
复合年增长率 14.5%

药物筛检涉及检测血液、尿液、毛髮、唾液或汗水等生物样本，以检测药物或其代谢物。市场涵盖各种用于药物检测的工具和服务，包括免疫分析仪、色谱系统、呼吸分析仪、口腔液体检测试剂盒和快速检测设备等检测设备。实验室筛检和现场筛检都是业界常用的方法。

该产品细分市场占据了最大的市场份额，2024年价值达81亿美元。此细分市场包括免疫分析仪、色谱仪和呼吸分析仪等重要工具，这些工具对于提供准确可靠的检测结果至关重要。快速检测设备因其便携性、易用性和即时结果的能力而特别抢手，是工作场所和紧急检测场景的理想选择。样本采集套件、校准套件和控制装置等耗材也需求旺盛，因为它们使用频繁，需要定期补充。

2024年，尿液药物检测占最大份额，达53.8%，预计预测期内将进一步成长。尿液检测因其成本效益高、可靠性高且能够检测多种物质，仍是最广泛使用的方法。由于代谢物会随尿液排出，因此尿液是识别近期药物使用情况的理想样本。尿液检测通常用于工作场所药物检测、入职前筛检和復健计画。其非侵入式采集方法以及检测大麻素、鸦片类药物、苯丙胺和苯二氮平类药物等物质的能力，使其成为药物滥用管理计画中不可或缺的一部分。

2024年，北美药物筛检市场规模达59亿美元，预计2034年将达212亿美元，复合年增长率达14%。北美市场引领市场，这得益于严格的监管要求、技术创新以及高度的工作场所安全意识。美国的监管框架，包括交通部（DOT）和药物滥用与精神健康服务管理局（SAMHSA）的授权，要求在交通运输、医疗保健和政府等各行各业进行药物检测。

全球药物筛选市场的主要参与者包括雅培、安捷伦、Dragerwerk、美国实验室公司 (LabCorp)、Quest Diagnostics、赛默飞世尔科技、罗氏和 Lifeloc Technologies 等公司。这些公司合计占有相当大的市场份额，在推动创新、法规遵循和开发高效能的药物检测技术方面发挥重要作用。为了提升市场地位，药物筛选市场的公司专注于多种策略。领先的公司正在大力投资研发，以创新和提高检测技术的准确性和速度。他们也正在扩大产品组合，以满足医疗保健、就业和执法等广泛行业的需求。他们也正在与研究机构和其他企业建立策略伙伴关係和合作关係，以扩大市场范围。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 毒品和酒精消费量不断增加
      • 有严格的法律支援药物筛选
      • 药物滥用检测产品和服务日益普及
    • 产业陷阱与挑战
      • 禁止工作场所药物测试
      • 缺乏训练有素的实验室专业人员
    • 市场机会
      • 工作场所越来越多地采用药物检测政策
      • 发展中国家意识的提高与政策执行的加强
  • 成长潜力分析
  • 监管格局
  • 技术和创新格局
  • 差距分析
  • 2024 年按产品和服务分類的药物筛选量分析
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 按产品和服务进行的公司份额分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 伙伴关係和合作
    • 扩张计划

第五章：市场估计与预测：按组件，2021 - 2034 年

  • 主要趋势
  • 产品
    • 分析仪器
      • 免疫分析仪
      • 色谱分析仪
      • 呼吸分析仪
      • 口腔液体检测分析仪
    • 快速检测设备
    • 耗材
  • 药物筛选服务

第六章：市场估计与预测：依样本类型，2021 - 2034 年

  • 主要趋势
  • 尿
  • 气息
  • 口腔液体
  • 头髮
  • 其他样本类型

第七章：市场估计与预测：按药物类型，2021 - 2034 年

  • 主要趋势
  • 大麻
  • 阿片类药物
  • 酒精
  • 安非他明
  • 其他药物类型

第八章：市场估计与预测：依最终用途，2021 - 2034 年

  • 主要趋势
  • 药物检测实验室
  • 工作场所
  • 医院
  • 执法机构
  • 其他最终用途

第九章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • Abbott
  • Agilent
  • Alcohol Countermeasure Systems
  • Alfa Scientific Designs
  • Dragerwerk
  • Eurofins Scientific
  • F. Hoffmann-La Roche
  • Laboratory Corporation of America (LabCorp)
  • Lifeloc Technologies
  • Omega Laboratories
  • OraSure Technologies
  • PerkinElmer
  • Premier Biotech
  • Psychemedics
  • Quest Diagnostics
  • Shimadzu
  • Siemens Healthineers
  • Thermo Fisher Scientific
简介目录
Product Code: 5971

The Global Drug Screening Market was valued at USD 13.8 billion in 2024 and is estimated to grow at a CAGR of 14.5% to reach USD 52.2 billion by 2034. This growth can be attributed to an increasing focus on addressing substance abuse issues, advancements in drug testing technologies, and the rise of stricter policies in various sectors, including employment, sports, and healthcare. Governments worldwide are intensifying efforts to combat drug abuse, which is further spurring market demand for effective screening solutions.

Drug Screening Market - IMG1

Cutting-edge technologies like liquid chromatography-mass spectrometry (LC-MS) and immunoassays have significantly improved the accuracy and efficiency of drug screening processes. Moreover, the rise in accessibility to rapid screening kits and on-site testing devices is making the process more convenient and reducing the time required for results. This has made drug screening solutions indispensable for workplace safety and compliance, especially under regulations like the Drug-Free Workplace Act, which has become a driving force behind the market's expansion.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$13.8 Billion
Forecast Value$52.2 Billion
CAGR14.5%

Drug screening involves testing biological samples such as blood, urine, hair, saliva, or sweat to detect drugs or their metabolites. The market encompasses a wide range of tools and services designed for drug detection, including testing devices such as immunoassay analyzers, chromatography systems, breath analyzers, oral fluid testing kits, and rapid test devices. Both laboratory and on-site screenings are common methods used in the industry.

The product segment accounted for the largest share of the market, valued at USD 8.1 billion in 2024. This segment includes essential tools such as immunoassay analyzers, chromatographic instruments, and breath analyzers, which are pivotal in delivering accurate and reliable results. Rapid testing devices are particularly in demand due to their portability, ease of use, and ability to provide immediate results, which makes them ideal for use in workplace and emergency testing scenarios. Consumables like sample collection kits, calibration kits, and control devices are also in high demand, as they are used frequently and require regular replenishment.

The urine-based drug testing segment held the largest share of 53.8% in 2024, with further growth anticipated during the forecast period. Urine testing remains the most widely used method due to its cost-effectiveness, reliability, and ability to detect a broad range of substances. Since metabolites are excreted in urine, it serves as an ideal sample for identifying recent drug use. Urine tests are commonly used for workplace drug testing, pre-employment screenings, and rehabilitation programs. Their non-invasive collection method and ability to detect substances like cannabinoids, opioids, amphetamines, and benzodiazepines make them indispensable in substance abuse management programs.

North America Drug Screening Market generated USD 5.9 billion in 2024 and is projected to reach USD 21.2 billion by 2034, growing at a CAGR of 14%. North America leads the market, driven by stringent regulatory requirements, technological innovations, and high awareness of workplace safety. The regulatory framework in the U.S., including mandates by the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA), requires drug testing in various industries, including transportation, healthcare, and government.

Key players in the Global Drug Screening Market include companies such as Abbott, Agilent, Dragerwerk, Laboratory Corporation of America (LabCorp), Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, and Lifeloc Technologies. These companies collectively hold a substantial portion of the market share and are instrumental in driving innovation, regulatory compliance, and developing efficient drug testing technologies. To enhance their market position, companies in the drug screening market focus on several strategies. Leading players are heavily investing in research and development to innovate and improve the accuracy and speed of testing technologies. They are also expanding their product portfolios to cater to a wide range of industries, including healthcare, employment, and law enforcement. Strategic partnerships and collaborations with research institutions and other businesses are also being formed to expand their market reach.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Component
    • 2.2.3 Sample type
    • 2.2.4 Drug type
    • 2.2.5 End use
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing drug and alcohol consumption
      • 3.2.1.2 Presence of stringent laws to support drug screening
      • 3.2.1.3 Growing availability of products and services for drug-of abuse testing
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Prohibition on workplace drug testing
      • 3.2.2.2 Dearth of trained laboratory professionals
    • 3.2.3 Market opportunities
      • 3.2.3.1 Growing adoption of drug testing policies in workplaces
      • 3.2.3.2 Rising awareness and policy enforcement in developing countries
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology and innovation landscape
  • 3.6 Gap analysis
  • 3.7 Drug screening volume analysis, by product and service, 2024
    • 3.7.1 North America
    • 3.7.2 Europe
    • 3.7.3 Asia Pacific
    • 3.7.4 Latin America
    • 3.7.5 MEA
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company share analysis, by product and service
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 Expansion plans

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Product
    • 5.2.1 Analytical instruments
      • 5.2.1.1 Immunoassay analyzers
      • 5.2.1.2 Chromatographic analyzers
      • 5.2.1.3 Breath analyzers
      • 5.2.1.4 Oral fluid testing analyzers
    • 5.2.2 Rapid testing devices
    • 5.2.3 Consumables
  • 5.3 Drug screening services

Chapter 6 Market Estimates and Forecast, By Sample Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Urine
  • 6.3 Breath
  • 6.4 Oral fluids
  • 6.5 Hair
  • 6.6 Other sample types

Chapter 7 Market Estimates and Forecast, By Drug Type, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cannabis/ marijuana
  • 7.3 Opiods
  • 7.4 Alcohol
  • 7.5 Amphetamines
  • 7.6 Other drug types

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Drug testing laboratories
  • 8.3 Workplace
  • 8.4 Hospitals
  • 8.5 Law enforcement agencies
  • 8.6 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Abbott
  • 10.2 Agilent
  • 10.3 Alcohol Countermeasure Systems
  • 10.4 Alfa Scientific Designs
  • 10.5 Dragerwerk
  • 10.6 Eurofins Scientific
  • 10.7 F. Hoffmann-La Roche
  • 10.8 Laboratory Corporation of America (LabCorp)
  • 10.9 Lifeloc Technologies
  • 10.10 Omega Laboratories
  • 10.11 OraSure Technologies
  • 10.12 PerkinElmer
  • 10.13 Premier Biotech
  • 10.14 Psychemedics
  • 10.15 Quest Diagnostics
  • 10.16 Shimadzu
  • 10.17 Siemens Healthineers
  • 10.18 Thermo Fisher Scientific